Activest Wealth Management Buys 72 Shares of Cigna Group $CI

Activest Wealth Management grew its stake in Cigna Group (NYSE:CI) by 360.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 92 shares of the health services provider’s stock after acquiring an additional 72 shares during the quarter. Activest Wealth Management’s holdings in Cigna Group were worth $30,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in CI. Brighton Jones LLC boosted its holdings in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its holdings in Cigna Group by 0.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 57,003 shares of the health services provider’s stock worth $15,741,000 after acquiring an additional 225 shares in the last quarter. Meiji Yasuda Life Insurance Co boosted its holdings in Cigna Group by 3.6% in the fourth quarter. Meiji Yasuda Life Insurance Co now owns 1,166 shares of the health services provider’s stock worth $322,000 after acquiring an additional 40 shares in the last quarter. Gallagher Fiduciary Advisors LLC raised its stake in shares of Cigna Group by 16.6% in the fourth quarter. Gallagher Fiduciary Advisors LLC now owns 1,142 shares of the health services provider’s stock worth $315,000 after purchasing an additional 163 shares during the last quarter. Finally, AlTi Global Inc. lifted its holdings in shares of Cigna Group by 20.0% during the fourth quarter. AlTi Global Inc. now owns 859 shares of the health services provider’s stock valued at $241,000 after purchasing an additional 143 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Up 0.8%

Cigna Group stock opened at $301.39 on Friday. The stock has a market cap of $80.45 billion, a PE ratio of 16.45, a price-to-earnings-growth ratio of 0.88 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a one year low of $256.89 and a one year high of $370.83. The stock has a fifty day moving average of $299.56 and a 200 day moving average of $311.85.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group’s dividend payout ratio is 32.97%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CI shares. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Barclays lowered their price target on Cigna Group from $385.00 to $354.00 and set an “overweight” rating on the stock in a report on Friday, August 1st. Morgan Stanley upped their price target on Cigna Group from $379.00 to $390.00 and gave the company an “overweight” rating in a report on Monday, May 5th. Finally, Truist Financial upped their price target on Cigna Group from $385.00 to $405.00 and gave the company a “buy” rating in a report on Monday, May 12th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $374.82.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.70% of the stock is currently owned by insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.